To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
908 Devices goes public
Boston-based 908 Devices, a provider of analytical devices for chemical and biomolecular analysis, has raised $130 million for its IPO after pricing its 6.5 million shares at $20 per share.
